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Abstract
Background: We investigated the encapsulation mechanism of enzymes into liposomes. The
existing protocols to achieve high encapsulation efficiencies are basically optimized for chemically
stable molecules. Enzymes, however, are fragile and encapsulation requires in addition the
preservation of their functionality. Using acetylcholinesterase as a model, we found that most
protocols lead to a rapid denaturation of the enzyme with loss in the functionality and therefore
inappropriate for such an application. The most appropriate method is based on lipid film hydration
but had a very low efficiency.
Results: To improve it and to propose a standard procedure for enzyme encapsulation, we
separate each step and we studied the effect of each parameter on encapsulation: lipid and buffer
composition and effect of the different physical treatment as freeze-thaw cycle or liposomes
extrusion. We found that by increasing the lipid concentration, increasing the number of freeze-
thaw cycles and enhancing the interactions of the enzyme with the liposome lipid surface more than
40% of the initial total activity can be encapsulated.
Conclusion: We propose here an optimized procedure to encapsulate fragile enzymes into
liposomes. Optimal encapsulation is achieved by induction of a specific interaction between the
enzyme and the lipid surface.
Background
Genomics studies and molecular biology evolutions in
mutagenesis have brought to us a large quantity of differ-
ent proteins, and notably enzymes, that would be useful
to biotechnology. Different applications may be consid-
ered such as their use in biosensors, protein chips or as
biocatalysts. However, most enzymes are fragile and any
of their conformational changes may induce a loss of ac-
tivity. Therefore their stabilization is required. One possi-
bility to is to encapsulate the protein into nanometer sized
vesicles. This method protects the enzyme from self dena-
turation due to dilution effects and furthermore protect
the enzyme from the aggression by external agents such as
proteases [1]. Beyond its stabilizing effect, enzymes en-
capsulation put forward other assets that biotechnological
applications may benefit from. For example, encapsula-
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tion allows to control indirectly the enzyme specificity; by
entrapping different porines in the liposomes mem-
branes, it is possible to regulate substrates entrance or
products exit from the vesicle [1,2]. Another application
of encapsulation is the delivering of actives molecules for
treatment of malignancy [3,4].
Nanometer sized capsules can be readily prepared upon
rehydrating lipid films. The size calibration is usually per-
formed by ultrasonic irradiation, extrusion through a fil-
ter of calibrated pore size, centrifugation or molecular
sieve chromatography. However, liposomes are unstable
and are therefore not suited for many applications. Lipo-
somes can be stabilised by adding hydrophobic mono-
mers of a polymer. The monomer will participate into the
hydrophobic core of the lipid. Crosslinking can be in-
duced by UV light or temperature [5]. Another possibility
to create long term stable vesicles is to formulate them us-
ing diblock or triblock copolymers leading to mechanical
and chemical stable nanocapsules while preserving the
membrane fluidity [6]. Both techniques lead to stable na-
nometer sized vesicles.
To encapsulate molecules in vesicles, several methods can
be used. In a first method, lipids are dissolved in a suitable
organic solvent, mixed with an aqueous medium fol-
lowed by removal of the solvent [7]. In a second method,
mixed lipid-detergent micelles are prepared and detergent
is eliminated by dialysis below its critical micellar concen-
tration [8]. We tested both approaches but the protein was
denatured either by organic solvents or by detergent. A
third popular method is the lipid film's hydration: a phos-
pholipid solution in chloroform is dried under vacuum to
obtain a lipid film; this lipid film is subsequently hydrat-
ed in a solution containing the protein [9,10]. This meth-
od allows to encapsulate proteins in its functional form
but efficiency of encapsulation was weak.
Our purpose was to improve the film hydration method
for loading liposomes with proteins while preserving their
functionality. We chose to encapsulate Drosophila mela-
nogaster acetylcholinesterase (AChE) as a reporter enzyme
because of the availability of an easy and accurate func-
tional assay. Moreover, this type of enzyme is highly inter-
esting as a biosensor to detect insecticide residues and
many groups are trying to develop an adequate detection
systems [11,12]. Here, we show following our suggestion
that 40% of the initial active enzyme can be encapsulated
without any denaturation.
Results
Effect of lipid concentration
In a first series of experiments, we investigated the influ-
ence of the lipid concentration on the encapsulation. Var-
ious amounts of egg PC and POPS (from 0.5 to 10 mg in
0.1 to 1 ml buffer) were used and the encapsulation effi-
ciency of AChE was recorded. Figure 1 clearly shows a lin-
ear relationship between the lipid concentration and the
encapsulation efficiency. The liposome surface is propor-
tional to the lipid concentration, in contrast the encapsu-
lated inner volume is proportional to the lipid
concentration to the power 3/2. Thus a double logarith-
mic plot of the encapsulated activity versus lipid concen-
tration allows to discriminate between the relevant
parameter. For eggPC and POPC lipids, values of the slope
(0.86 +/- 0.01 and 1.16 +/- 0.04, respectively) were close
to 1 suggesting that encapsulation is proportional to the
number of lipids and thus proportional to the surface; and
is significantly far from 1.5 relevant for encapsulation via
internal volume.
Effect of freeze-thaw number
Hydration of lipid films results in inhomogeneous multi-
lamellar vesicles. Application of a series of freeze-thaw cy-
cles breaks the multilamellar vesicles into unilamellar
vesicles. As each freeze-thaw cycle usually causes denatur-
ation of proteins, we investigated the effect number of
freeze-thaw on encapsulation. About 5 mg eggPC lipid
films were solubilized with 1 ml of a 25 mM MOPS pH 7
solution containing AChE. The tubes then underwent dif-
ferent numbers of freeze-thaw cycles from 0 to 20. The li-
posome solutions were then extruded. The encapsulation
efficiencies were compared and are shown in figure 2. We
observed an increase of encapsulation efficiency accord-
ing to the number of freeze-thaw cycles without signifi-
cant denaturation of the enzyme. This suggests that in the
lipid hydration method, the encapsulation mainly occurs
during the freeze thaw step. In the following experiments
we fix the freeze-thaw cycles to 10.
Figure 1
Effect of lipid concentration on AChE encapsulation. Two lip-
ids compsitions were used: egg POPC (red) and POPS (blue).BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/9
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Effect of extrusion
Vesicles formed by spontaneous swelling as described do
have a rather polydisperse size distribution [13]. Narrow
size distribution can be obtained by extruding the suspen-
sion through a filter of defined size. About 5 mg eggPC li-
pid films were solubilized with 1 ml of a 25 mM MOPS
pH7 solution containing AChE. Then the tubes under-
went ten freeze-thaw cycles and the liposome solutions
were then subjected to different numbers of extrusions
(from 0 to 20) through a disposable 200 nm cellulose ac-
etate pore filter. Surprisingly we observed a strong de-
crease of encapsulation efficiency with the first extrusion
and then a progressive recovery (Fig. 3). However, if the
solution is passed through a new filter, no recovery was
observed. This suggest the retension of much material in-
side the filter. Increasing the extrusion number did not re-
sult in an increase of encapsulation efficiency beyond the
encapsulation observed following the freeze-thaw step.
As several types of filters are available, we investigated the
effect on the composition of the filter on encapsulation ef-
ficiency (Fig. 4). AChE was encapsulated using the above
conditions with ten freeze-thaw cycles followed by ten ex-
trusions through a polycarbonate filter usually sold for
the liposome extruder (Fig. 4, line 1). After extrusion we
compared the final encapsulates enzymatic activity with
the initial total one. This gives the encapsulation efficien-
cy. In addition, we compared also the final total (encapsu-
lated and free enzyme) activity after extrusion with the
initial total one. This gives the enzyme recovery. This al-
lows an estimate of the amount of enzyme lost, either ad-
sorbed inside the filter or denaturated. We observed 20%
encapsulation without any significant loss of enzyme ac-
tivity with the polycarbonate filter. The same result was
obtained using disposable filter in cellulose acetate or in
regenerated cellulose (Fig. 4, line 2 and 3). With nylon fil-
ter (Fig. 4, line 4), the encapsulation is identical to encap-
sulation observed with cellulose acetate but recovery was
weak. Encapsulation and recovery were identical suggest-
ing that non-encapsulated AChE was retained on the
membrane while encapsulated AChE passes through the
filter. This result is consistent with the absence of effect of
extrusion on encapsulation which took place before, dur-
ing the freeze-thaw cycles. It is interesting to note that the
use of nylon filter shows an unexpected advantage: it per-
mits to remove the non-encapsulated enzymes without
any detrimental effect on encapsualtion. Extrusions per-
formed on membranes made of PTFE (polytetrafluoroeth-
ylene) and Cellulose Acetate with Glass Fiber
premembrane (Fig. 4, line 5 and 6) gave much lower en-
capsulation efficiencies. As these filters are hydrophobic,
we may hypothesize that retention of some vesicles or li-
pids occurred on these filters. Dynamic light scattering ex-
periments were done concurrently and in agreement with
published literature [13], a narrow size distributions were
obtained for all extruded liposomes solutions.
Effect of solution composition
In the following series of experiments, we investigated the
effect of the buffer composition on the encapsulation effi-
ciency. Four buffer compositions were tested: 25 mM Tris
HCl, 25 mM MOPS, 25 mM MES and 25 mM sodium
phosphate, all buffers were at pH 7. AChE was encapsulat-
ed under standart conditions as described above, and en-
capsulation efficiencies were compared. No significant
difference in the encapsulation efficiency was observed.
Several pH values were tested for the encapsulation of
AChE in 25 mM sodium phosphate buffer from 6.0 to 8.5,
Figure 2
Effect of freeze-thaw number on AChE encapsulation under
similar conditions as in figure 1.
Figure 3
Effect of extrusion number on AChE encapsulation. The filter
was made of polycarbonate under similar conditions as in fig-
ure 1.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/9
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with an increment of 0.5 and no significant difference in
the pH range we tested could be observed.
In the next step we tested the effect of the ionic strength.
Different concentrations of NaCl were used for the encap-
sulation of AChE from 10 µM to 1 M. It appeared that in-
creasing concentration of NaCl lowers encapsulation (Fig.
5). According to the Debye-Hückel theory, addition of
ions screens charged groups and leads to a reduction of
electrostatic interactions between the enzyme and the lip-
id film. The observed decrease of the encapsulation effi-
ciency while increasing the salts concentration suggests
that encapsulation is related to an interaction between
phospholipids and protein.
Effect of co-encapsulation of stabilizers
Most of proteins are denatured during freeze-thaw cycles.
Since this step of the encapsulation process is a key step
for the encapsulation efficiency, it cannot be skipped. One
solution to avoid denaturation of proteins sensible to
thermal fluctuations would be the coencapsulation of sta-
bilizers. Indeed, addition of stabilizing additives in pro-
tein formulations is the most common tool to increasing
the shelf life of the product. These compounds are often
chosen on an empirical basis since the protective effect of
solutes is variable, depending on protein characteristics.
We therefore tried to coencapsulate AChE with different
molecules (sugars, polymer or protein) usually employed
to stabilize enzymes and we checked if these molecules af-
fect encapsulation efficiencies. Here our enzyme was sta-
ble to resist the freeze-thaw cycle. We therefore
investigated if the coencapsulation reduces the activity of
the encapsulated enzyme. Mannose, sucrose and treha-
lose were coencapsulated at 100 mM with AChE as de-
scribed in materials and methods. It appeared that those
stabilizers did not affect encapsulation (data not shown),
suggesting that proteins that would be stabilized by those
sugars could be coencapsulated without any loss of effi-
ciency. PEG (polyethylene glycol) and BSA (bovine serum
albumin) protect the AChE from denaturation [14]. En-
zyme buffered solutions containing various concentra-
tions of PEG 3350 or BSA were used for encapsulation and
Figure 4
4A. Effect of filter composition on AChE encapsulation percentage: encapsulated enzymatic activity/ total activity. 4B. Enzyme
recovery percentage: Total enzymatic activity after extrusion/total enzymatic activity. The filter used were: Polycarbonate filter
specially designed for liposome extruder (line 1), Cellulose Acetate (line 2), Regenerated Cellulose (line 3), Nylon (line 4),
PTFE (polytetrafluoroethylene) (line 5) and Cellulose Acetate with a Glass Fiber premembrane (line 6).
Figure 5
Effect of NaCl concentration on AChE encapsulation under
similar conditions as in figure 1.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/9
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efficiencies were compared. It turned out that PEG 3350
and BSA strongly disfavors encapsulation (Fig. 6) suggest-
ing that PEG and BSA immobilize water molecules and
compete with AChE for interaction with phospholipids.
Effect of lipid composition
Different phospholipid compositions were used for the
formulation of liposomes loaded with AChE, and encap-
sulation efficiencies were compared. Liposomes with the
same polar head groups (eggPC and POPC) but with hy-
drocarbon chains of different length and saturation de-
grees had nearly the same encapsulation efficiencies (Fig.
7) suggesting that encapsulation efficiency does not de-
pend on the hydrophobic component of the phospholip-
id. Encapsulation efficiency was better with POPC than
with POPS (Fig. 1 and 7). Encapsulation was performed at
pH 8.5, the enzyme peripheral surface was globally nega-
tively charged. Surface of lipid membrane made with
POPC was neutral and surface of lipid membrane with
POPS was negatively charged. These data suggest that en-
capsulation depends on electrostatic interactions between
the enzyme peripheral surface and the polar head group
of phospholipids. With 5% of POPE, no significant encap-
sulation efficiency differences were observed.
Effect of lipids with a functional group to bind proteins on 
encapsulation efficiency
The previous experiments suggest that electrostatic inter-
actions between the enzyme and the lipidic surface favor
encapsulation. However, increasing the unspecific electro-
static interactions with the lipid surface is rather limited as
the ionic strength and the surface charge density of the
protein can only be varied within a small range. In order
to provide "universal method" for high efficient encapsu-
lation we then test the possibility to use a specific interac-
tion using the affinity of histidine tag for Nickel. The
AChE we used has three histidine tag in a peptidic loop ly-
ing at the surface of the protein. This enzyme binds to
NTA-Ni column chromatography confirming the func-
tionality of the histidine tag. 5 mg of eggPC mixed with
0.12 mg DOGS-NTA-Ni lipids were used to formulate 1
ml lipid suspension. In order to observe the enhancement
due to the specific interaction we minimize the electro-
static interaction by addition of 500 mM NaCl to the so-
lution. It appeared (Fig. 8) that the addition of DOGS-
NTA-Ni lipids in the composition of the liposomes en-
hanced the encapsulation efficiency of AChE.
Discussion
Several methods have been described to encapsulate mac-
romolecules. First assays using the dissolution of lipids in
a suitable organic solvent failed because the protein was
always denatured. Methods using mixed micelles of deter-
gents (n-octyl-β -D-glucopyranoside or CHAPS) according
to Mok et al. [15] also resulted to a denaturation of the en-
Figure 6
Effect of coencapsulation of stabilizers on AChE encapsula-
tion. The measurements were done under similar conditions
as in figure 1. (A) Encapsulation efficiency in absence (con-
trol) or with sugars (sucrose, mannose or trehalose). (B)
Encapsulation efficiency as function of Polyethylene Glycol
(PEG) concentration. (C) Encapsulation efficiency as function
of Bovine Serum Albumin (BSA) concentration.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/9
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zyme during the dialysis steps necessary to eliminate the
detergent molecules. Thus we turned to the film hydration
method and we performed various experiments to in-
crease the efficiency of active enzyme encapsulation.
In the film hydration method, several evidences suggest
that efficient encapsulation is obtained by favoring inter-
actions of the protein with the lipidic film during the
freeze-thaw cycles.
- AChE encapsulation efficiencies in PC liposomes was
better than that obtained with POPS liposomes. As the en-
zyme is negatively charged as well as POPS, we can hy-
pothesize that the difference in encapsulation is due to an
electrostatic interaction between the enzyme and the sur-
face of the lipidic wall.
- During the successive extrusions, the enzyme stayed in-
side the liposome suggesting that interaction between lip-
id membranes and the protein did not allow free
displacement of the protein.
- Encapsulation decreases with increase of salt concentra-
tion. This result leads to hypothesize that ionic strength
decreases electrostatic interactions between liposomes
wall and amino-acids present at the surface of the protein
resulting in a decreased encapsulation.
- With an His-tagged enzyme, the addition of DOGS-NTA-
Ni lipids in the liposome formulation induces a specific
interaction of the lipid with the enzyme, and thus allow
its better encapsulation.
A drawback of freeze-thaw cycles is the denaturation of
proteins. Stabilization of the enzyme by addition of pro-
tective compounds can be used. Utilization of a specific
interaction such as the Nickel-histidine interaction per-
mits to use stabilizers without any competition for the in-
teraction with the membrane. Neglecting the unexpected
adsorption of the material in the filter which can be recov-
ered after several repeated extrusion steps no reduction
nor an enhancement of the encapsulation efficiency could
be observed. Another interest of extrusion appeared when
we tested different filter materials: using filter surfaces
with a strong affinity for protein allows to eliminate non-
encapsulated protein from a solution.
Conclusions
We showed that the encapsulation efficiency of protein
depends on interaction between the protein and the lipid
bilayer. The enzyme entrapment can be increased by ma-
nipulation of the liposomal lipid composition, or by in-
creasing the lipid concentration, in order to favor
electrostatic interactions. Because of the important role of
those interactions during encapsulation, one has to take
care of the ionic strength of the enzyme solution, as ions
could hide electrostatic interactions, preventing a good
encapsulation efficiency. It is also possible to induce a
specific interactions such as an interaction between an
His-tagged enzyme and the lipid surface of the liposomes
by addition of DOGS-NTA-Ni lipids in their formulation.
Figure 7
Effect of lipid composition on AChE encapsulation. Effect of
eggPC, eggPC+5%POPE, POPC, POPS under similar condi-
tions as in figure 1.
Figure 8
Effect of addition of 1% DOGS-NTA-Ni to egg-PC lipids on
AChE encapsulation efficiency in presence of 0.5 M NaCl.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/9
Page 7 of 8
(page number not for citation purposes)
Material and methods
Materials
Lipids
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoeth-
anolamine (POPE), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoserine (POPS), 1,2-Dioleoyl-sn-Glycero-3-
{[N(5-Amino-1-Carboxypentyl)iminodiAcetic Acid]Suc-
cinyl}(Nickel salt) (DOGS-NTA-Ni), were from Avanti
Polar Lipids, Inc (Alabaster, AL) and eggPC extract (98%
pure) was from Lipoïd, Ludwigshafen.
Proteins
Pronase was purchased from Sigma (St. Louis, MO). Re-
combinant acetylcholinesterase was produced in baculo-
virus infected cells and purified by affinity
chromatography as previously described [14]. Drosophila
AChE is a dimer which is linked to the membrane via a
glycolipid anchor. This form can be converted to an hy-
drophilic dimer by expression of a truncated cDNA [16].
This hydrophilic form was used. Furthermore, each mon-
omer of the dimer was tagged with three histidines by site
directed mutagenesis using the QuickChange site-directed
mutagenesis kit from Stratagene.
Preparation of liposomes
Liposomes were prepared using the film hydration meth-
od. Under standard conditions, 5 mg of lipids in solution
in chloroform were dried at the bottom of a 8 ml tube for
15 min. under nitrogen gas stream and desiccated for 6 hr.
under vacuum. Multilamellar vesicles were obtained by
hydration of the film with 0.1 ml of 25 mM MOPS buffer
pH 8.5, containing 0.3 nmole of enzyme. The tube was
vortexed until the lipid film was peeled of from the tube
surface. To break the multilamellar vesicles into monola-
mellar, ten cycles of freezing (liquid nitrogen) and thaw-
ing (30°C water bath) were applied. The sample was then
diluted to 1 ml in 25 mM MOPS buffer pH 8.5. Size of li-
posome was homogenized by extrusion by passing the
sample 10 fold through a 200 nm pore polycarbonate fil-
ters unless otherwise indicated. Modifications of this
method are indicated for each experiment.
Quantification of the encapsulation efficiency
AChE activity is measured according Ellman [17]. AChE
catalyses the hydrolysis of acetylthiocholine, producing
acetate and thiocholine; thiocholine is then able to react
with di-thionitrobenzoic acid, producing a thiocholine
coupled with a thio-nitro-benzoic acid by a disulfide
bond and a thio-nitro-benzoate. This molecule is detecta-
ble by O.D. measurements at 412 nm with an ε  = 13600
M-1cm-1. AChE activity is equal to the absorbance varia-
tion plotted versus time.
To determine the fraction of encapsulated AChE, the solu-
tion was incubated in a solution of the proteolytic enzyme
pronase. Pronase does not pass through the liposomal bi-
layer and therefore the encapsulated AChE is protected
from enzymatic digestion. Free enzyme and enzyme
bound to the external surface of the liposome are inacti-
vated according to a first order kinetics. Variation of pro-
portion of remaining active enzyme amount ([E]/ [Eo])
with time (t) follows equation 1:
where A is the proportion of encapsulated enzyme and k
the rate constant of enzyme inactivation. To estimate [E] /
[Eo], the enzyme was incubated with 1 mg ml-1 pronase at
25°C in 25 mM phosphate buffer pH 7. The variation of
the remaining free enzyme [E] / [Eo] with time was esti-
mated by sampling aliquots at various times and record-
ing the remaining activity with 1 mM acetylthiocholine in
presence of 0.1% Triton X-100. The proportion of encap-
sulated enzyme (A) was estimated by non-linear regres-
sion with t as variable. As far as mixed lipid-detergent
micelles were found to be reversible inhibitors of AChE,
inhibition kinetics of AChE by POPC, POPS and eggPC
were recorded and the results shown in this paper take
those inhibitions in account.
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Abbreviations
AChE acetylcholinesterase
BSA bovine serum albumine
DOGS-NTA-Ni 1,2-Dioleoyl-sn-Glycero-3-{[N(5-Amino-
1-Carboxypentyl)iminodiAcetic Acid]Succinyl}(Nickel
salt)
EggPC egg extracted lipids with a Phospho-L-Choline po-
lar head
MOPS 3-[N-morpholino]propanesulfonic acid
PEG polyethylene glycol
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
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POPE 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoeth-
anolamine
POPS 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine
PTFE polytetrafluoroethylene
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